Tobacco prevention & cessation · 2026
Patient and healthcare system factors associated with participation in municipal smoking cessation programs after hospitalization for atherosclerotic vascular disease in Norway: A prespecified analysis of two randomized controlled trials.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Getz Vilde, Pleym Karin, Dammen Toril, Husebye Einar, Sverre Elise, Peersen Kari, Papageorgiou Costas, Weedon-Fekjær Harald, Munkhaugen John
Аннотация
INTRODUCTION: Persistent smoking after hospitalization for an atherosclerotic vascular event remains common, and only a small proportion attend cardiac rehabilitation or community-based lifestyle support, including smoking cessation programs. This study aimed to identify patient and healthcare system factors associated with participation in a municipal smoking cessation program among patients with atherosclerotic vascular disease included in a smoking cessation trial.
METHODS: A prespecified secondary analysis was conducted of two randomized cessation trials with patients recruited between 2021 and 2023 at three hospitals in Norway. Hospitalized patients with established atherosclerotic vascular disease who smoked at least one cigarette daily were randomized to motivational counseling with proactive referral to the municipal cessation program (intervention) or brief advice and contact information (control). Data were collected from medical records and self-report questionnaires. Associations between patient and healthcare system factors and program participation were explored using logistic regression analyses, adjusting for age, site and group allocation.
RESULTS: In all, 268 of 280 patients were eligible at 6 months (median age 65 years, 39% women). Participation in the cessation program was 42% (56/134) in the intervention and 9% (12/134) in the control group. Among participants, 57% (39/68) quit smoking, compared with 30% (59/200) among non-participants. In the total sample, older age (adjusted odds ratio, AOR=0.65 per 10 year increase; 95% CI: 0.47-0.90), living alone versus with others (AOR=0.30; 95% CI: 0.14-0.65), and lower versus higher education (AOR=0.40; 95% CI: 0.18-0.89) were negatively associated with participation. Analysis restricted to the intervention group yielded consistent findings.
CONCLUSIONS: Participation in a municipal smoking cessation program among hospitalized patients with atherosclerotic vascular disease remained suboptimal, despite proactive motivational counseling and proactive referral. Older patients, those living alone, and patients with lower level of education were less likely to participate, highlighting the need for targeted referral strategies and tailored support for these groups.
METHODS: A prespecified secondary analysis was conducted of two randomized cessation trials with patients recruited between 2021 and 2023 at three hospitals in Norway. Hospitalized patients with established atherosclerotic vascular disease who smoked at least one cigarette daily were randomized to motivational counseling with proactive referral to the municipal cessation program (intervention) or brief advice and contact information (control). Data were collected from medical records and self-report questionnaires. Associations between patient and healthcare system factors and program participation were explored using logistic regression analyses, adjusting for age, site and group allocation.
RESULTS: In all, 268 of 280 patients were eligible at 6 months (median age 65 years, 39% women). Participation in the cessation program was 42% (56/134) in the intervention and 9% (12/134) in the control group. Among participants, 57% (39/68) quit smoking, compared with 30% (59/200) among non-participants. In the total sample, older age (adjusted odds ratio, AOR=0.65 per 10 year increase; 95% CI: 0.47-0.90), living alone versus with others (AOR=0.30; 95% CI: 0.14-0.65), and lower versus higher education (AOR=0.40; 95% CI: 0.18-0.89) were negatively associated with participation. Analysis restricted to the intervention group yielded consistent findings.
CONCLUSIONS: Participation in a municipal smoking cessation program among hospitalized patients with atherosclerotic vascular disease remained suboptimal, despite proactive motivational counseling and proactive referral. Older patients, those living alone, and patients with lower level of education were less likely to participate, highlighting the need for targeted referral strategies and tailored support for these groups.